Skip to main content
. Author manuscript; available in PMC: 2006 Feb 7.
Published in final edited form as: Oncogene. 2005 Oct 13;24(45):6773–6784. doi: 10.1038/sj.onc.1208833

Figure 4.

Figure 4

Effects of DHT on caspase activity in LNCaP-si-E6 (mock transfectant) and LNCaP-si-p53. Cells were pretreated for 48 h with indicated concentrations of DHT and then treated for 3 h with wortmannin (1 μm) plus TNF-α (20 ng/ml) or with wortmannin plus TRAIL (100 ng/ml). Caspase activity was estimated in cell lysates with the substrate Ac-DEVD-AMC